Patents by Inventor David L. Larson

David L. Larson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158837
    Abstract: Provided herein are methods of identifying genomic region(s) predictive of an outcome of treatment with a cell therapy and/or of a phenotype of function of the cells. In some embodiments, the methods include epigenetic and/or epigenomic analyses of the cells in connection with methods for preparing engineered cells for cell therapy and/or predicting response to a cell therapy, e.g., engineered cells for cell therapy. In some embodiments, the methods include steps to assess, characterize and analyze changes or modifications in an epigenetic property of gene region or regions, such as chromatin accessibility, nucleosome occupancy, histone modification, spatial chromosomal conformation, transcription factor occupancy and/or DNA methylation. In some embodiments, the epigenetic and/or epigenomic analysis includes determining the epigenetic properties of a cell, e.g., an engineered cell for cell therapy.
    Type: Application
    Filed: October 17, 2023
    Publication date: May 16, 2024
    Applicant: Juno Therapeutics, Inc.
    Inventors: Mark L. BONYHADI, David G. KUGLER, Timothy G. JOHNSTONE, Ronald James HAUSE, Jr., Lucas J. THOMPSON, Ryan P. LARSON
  • Publication number: 20240110116
    Abstract: A process of making a fuel product as an additive from a non-auto-combustible high protein organic material for the destruction of polyfluoro compounds in a thermal process system is provided. Thermal reactions within thermal reaction equipment are controlled by controlling the moisture and oxygen in the reaction atmosphere of the equipment and energy inputs at or downstream of a thermal reaction chamber. The concentration of protein thermal decomposition by-products, temperature, and residence time and/or additions of energy within the thermal reaction equipment environment are controlled to destroy hazardous polyfluoro compounds.
    Type: Application
    Filed: October 20, 2023
    Publication date: April 4, 2024
    Applicant: AKBEV GROUP, LLC
    Inventors: Geoffrey L. Larson, Curtis Holmes, Brandon Michael Smith, David D. Wilson
  • Patent number: 4994457
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of a non-steroidal antiinflammatory agent such as piroxicam, or a pharmaceutically acceptable salt thereof, with 5'-guanylic acid or N-acetyl-L-methionine, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 19, 1987
    Date of Patent: February 19, 1991
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, David L. Larson, Joseph G. Lombardino
  • Patent number: 4960242
    Abstract: An asphalt distributor has a spray bar assembly that includes at least one extendable and retractable spray bar section for extending the overall width of the spray bar assembly beyond the lateral sides of a vehicle supporting the assembly. The extendable and retractable section includes a manifold tube that carries the asphalt to be sprayed, and which tube is in turn supported on a hydraulic actuator that is used for extending and retracting the associated manifold tube. The manifold tube is provided with a plurality of spray valve assemblies that are operated in a way so that the valves are turned on to permit spraying automatically as the spray bar manifold is extended laterally outwardly, and turn off the spray for the respective valve assembly as the manifold tube is retracted.
    Type: Grant
    Filed: July 28, 1988
    Date of Patent: October 2, 1990
    Assignee: Rosco Manufacturing Company
    Inventor: David L. Larson
  • Patent number: 4874757
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of antiinflammatory piroxicam, or a pharmaceutically acceptable salt thereof, with analgesic acetaminophen, antidepressant doxepin, bronchodilator pirbuterol, minor tranquilizer diazepam, or antihypertensive trimazosin.
    Type: Grant
    Filed: November 4, 1988
    Date of Patent: October 17, 1989
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4812455
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of antiinflammatory piroxicam, or a pharmaceutically acceptable salt thereof, with analgesic acetaminophen, antidepressant doxepin, bronchodilator pirbuterol, minor tranquilzer diazepam, or antihypertensive trimazosin.
    Type: Grant
    Filed: April 11, 1988
    Date of Patent: March 14, 1989
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4766117
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of antiinflammatory piroxicam, or a pharmaceutically acceptable salt thereof, with analgesic acetaminophen, antidepressant doxepin, bronchodilator pirbuterol, minor tranquilizer diazepam, or antihypertensive trimazosin.
    Type: Grant
    Filed: December 12, 1986
    Date of Patent: August 23, 1988
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4672061
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of antiinflammatory piroxicam, or a pharmaceutically acceptable salt thereof, with analgesis acetaminophen, antidepressant doxepin, bronchodilator pirbuterol, minor tranquilizer diazepam, or antihypertensive trimazosin.
    Type: Grant
    Filed: January 21, 1986
    Date of Patent: June 9, 1987
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4591595
    Abstract: 2-Guanidino-4-(2-methyl-4-imidazolyl)thiazole and 2-(N-pentyl-N'-guanidino)-4-(2-methyl-4-imidazolyl)thiazole, histamine-H.sub.2 antagonist useful as a gastric acid antisecretory and antiulcer agents, are also useful per se in the treatment of rheumatoid arthritis.
    Type: Grant
    Filed: August 9, 1985
    Date of Patent: May 27, 1986
    Assignee: Pfizer Inc.
    Inventor: David L. Larson
  • Patent number: 4579846
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of antiinflammatory piroxicam, or a pharmaceutically acceptable salt thereof, with analgesic acetaminophen, antidepressant doxepin, bronchodilator pirbuterol, minor tranquilizer diazepam, or antihypertensive trimazosin.
    Type: Grant
    Filed: January 28, 1985
    Date of Patent: April 1, 1986
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4564614
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of a non-steroidal antiinflammatory agent such as piroxicam, or a pharmaceutically acceptable salt thereof, with pyridoxine.
    Type: Grant
    Filed: January 28, 1985
    Date of Patent: January 14, 1986
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4559326
    Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of a non-steroidal antiinflammatory agent such as prioxicam, or a pharmaceutically acceptable salt thereof, with inositol.
    Type: Grant
    Filed: January 31, 1985
    Date of Patent: December 17, 1985
    Assignee: Pfizer Inc.
    Inventors: Thomas C. Crawford, Stanley L. Keely, David L. Larson, Joseph G. Lombardino, James J. Maciejko
  • Patent number: 4543414
    Abstract: 2-Substituted-2-oxazolines are prepared by contacting N-(2-hydroxyalkyl)carboxamides with a small but catalytic amount of a cadmium or zinc salt at an elevated temperature.
    Type: Grant
    Filed: August 14, 1980
    Date of Patent: September 24, 1985
    Assignee: The Dow Chemical Company
    Inventor: David L. Larson
  • Patent number: 4354029
    Abstract: 2-Substituted-2-oxazolines are prepared by contacting N-(2-hydroxyalkyl)carboxamides with a small but catalytic amount of an organic zinc salt at an elevated temperature.
    Type: Grant
    Filed: November 30, 1981
    Date of Patent: October 12, 1982
    Assignee: The Dow Chemical Company
    Inventors: Mark E. Kaiser, David L. Larson
  • Patent number: 4352390
    Abstract: Partially devitrified silica cores with exceptional high temperature strength are disclosed for foundry use in sand casting of ferrous alloys. Precision cored holes of small size and long length, which heretofore could not be cast accurately or had to be machined because of limitations in existing core technology, are formed using accurately machined extruded porous silica cores fired to eliminate combustibles and partially devitrified (e.g., 15 to 30%) to develop a strong crystalline phase bond that resists viscous flow at a temperature of 1500.degree. C. and to increase the refractoriness of the vitreous silica grains, whereby the permeability and thermal shock resistance are such that the core can be heated very rapidly by molten steel to above 1500.degree. C. without spalling, cracking, sagging, breaking, or loss of integrity and without gas holes, scabs, fissures or other serious casting defects.
    Type: Grant
    Filed: September 12, 1980
    Date of Patent: October 5, 1982
    Assignee: Sherwood Refractories, Inc.
    Inventor: David L. Larson
  • Patent number: 4236568
    Abstract: Partially devitrified silica cores with exceptional high temperature strength are disclosed for foundry use in sand casting of ferrous alloys. Precision cored holes of small size and long length, which heretofore could not be cast accurately or had to be machined because of limitations in existing core technology, are formed using accurately machined extruded porous silica cores fired to eliminate combustibles and partially devitrified (e.g., 15 to 30%) to develop a strong crystalline phase bond that resists viscous flow at a temperature of 1500.degree. C. and to increase the refractoriness of the vitreous silica grains, whereby the permeability and thermal shock resistance are such that the core can be heated very rapidly by molten steel to above 1500.degree. C. without spalling, cracking, sagging, breaking, or loss of integrity and without gas holes, scabs, fissures or other serious casting defects.
    Type: Grant
    Filed: December 4, 1978
    Date of Patent: December 2, 1980
    Assignee: Sherwood Refractories, Inc.
    Inventor: David L. Larson